Overview

Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether iloperidone is effective in the treatment of Schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Treatments:
Iloperidone
Risperidone